Literature DB >> 21187316

Clinical report—bone densitometry in children and adolescents.

Laura K Bachrach, Irene N Sills.   

Abstract

Concern for bone fragility in children and adolescents has led to increased interest in bone densitometry. Pediatric patients with genetic and acquired chronic diseases, immobility, and inadequate nutrition may fail to achieve the expected gains in bone size, mass, and strength, which leaves them vulnerable to fracture. In older adults, bone densitometry has been shown to predict fracture risk and reflect response to therapy. The role of densitometry in the management of children at risk of bone fragility is less certain. This clinical report summarizes the current knowledge about bone densitometry in the pediatric population, including indications for its use, interpretation of results, and its risks and costs. This report emphasizes consensus statements generated at the 2007 Pediatric Position Development Conference of the International Society of Clinical Densitometry by an international panel of bone experts. Some of these recommendations are evidence-based, and others reflect expert opinion, because the available data are inadequate. The statements from this and other expert panels have provided general guidance to the pediatrician, but decisions about ordering and interpreting bone densitometry still require clinical judgment. Ongoing studies will help to better define the indications and best methods for assessing bone strength in children and the clinical factors that contribute to fracture risk.

Entities:  

Mesh:

Year:  2010        PMID: 21187316     DOI: 10.1542/peds.2010-2961

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  38 in total

1.  Pediatrics: Measuring pediatric BMD-the bar raised but the glass half full.

Authors:  Craig B Langman
Journal:  Nat Rev Endocrinol       Date:  2011-11-22       Impact factor: 43.330

Review 2.  State of the art systematic review of bone disease in anorexia nervosa.

Authors:  Madhusmita Misra; Neville H Golden; Debra K Katzman
Journal:  Int J Eat Disord       Date:  2015-08-27       Impact factor: 4.861

3.  Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents.

Authors:  Chadi A Calarge; Stephanie D Ivins; Katherine J Motyl; Amal A Shibli-Rahhal; Michael M Bliziotes; Janet A Schlechte
Journal:  Ther Adv Psychopharmacol       Date:  2013-10

4.  Risk of fracture prevention in spina bifida patients: correlation between bone mineral density, vitamin D, and electrolyte values.

Authors:  V Martinelli; C Dell'Atti; E Ausili; E Federici; N Magarelli; A Leone; L Massimi; C Di Rocco; L Bonomo; C Rendeli
Journal:  Childs Nerv Syst       Date:  2015-05-01       Impact factor: 1.475

5.  Pediatric solid organ transplantation and osteoporosis: a descriptive study on bone histomorphometric findings.

Authors:  Inari S Tamminen; Helena Valta; Hannu Jalanko; Sari Salminen; Mervi K Mäyränpää; Hanna Isaksson; Heikki Kröger; Outi Mäkitie
Journal:  Pediatr Nephrol       Date:  2014-02-23       Impact factor: 3.714

6.  Serum Sclerostin Level and Bone Mineral Density in Pediatric Hemophilic Arthropathy.

Authors:  Dalia M E El-Mikkawy; Mohja A Elbadawy; Shereen M Abd El-Ghany; Dalia Samaha
Journal:  Indian J Pediatr       Date:  2019-01-22       Impact factor: 1.967

7.  Use of dual energy X-ray absorptiometry in pediatric patients.

Authors:  Halley Wasserman; Jennifer M O'Donnell; Catherine M Gordon
Journal:  Bone       Date:  2016-12-15       Impact factor: 4.398

8.  Update on stress fractures in female athletes: epidemiology, treatment, and prevention.

Authors:  Yin-Ting Chen; Adam S Tenforde; Michael Fredericson
Journal:  Curr Rev Musculoskelet Med       Date:  2013-06

Review 9.  Diagnosis and treatment of osteopenic fractures in children.

Authors:  Charles T Mehlman; Marcia A Shepherd; Carie S Norris; Jessica B McCourt
Journal:  Curr Osteoporos Rep       Date:  2012-12       Impact factor: 5.096

10.  Reduced bone density in patients with autosomal dominant hyper-IgE syndrome.

Authors:  Oded Scheuerman; Vered Hoffer; Avner Herman Cohen; Cristina Woellner; Bodo Grimbacher; Ben-Zion Garty
Journal:  J Clin Immunol       Date:  2013-04-19       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.